Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

188 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.
Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Lettieri CJ, et al. Among authors: nathan sd. Chest. 2006 Mar;129(3):746-52. doi: 10.1378/chest.129.3.746. Chest. 2006. PMID: 16537877
PAH was present in 31.6% of patients (mean [+/- SD] mPAP, 29.5 +/- 3.3 vs 19.1 +/- 3.7 mm Hg, respectively). Those patients with PAH had a lower mean diffusing capacity of the lung for carbon monoxide (Dlco) (37.6 +/- 11.3% vs 31.1 +/- 10.1%, respectively; p = 0.04) and we …
PAH was present in 31.6% of patients (mean [+/- SD] mPAP, 29.5 +/- 3.3 vs 19.1 +/- 3.7 mm Hg, respectively). Those patients with PAH …
Aspergillus and endobronchial abnormalities in lung transplant recipients.
Nathan SD, Shorr AF, Schmidt ME, Burton NA. Nathan SD, et al. Chest. 2000 Aug;118(2):403-7. doi: 10.1378/chest.118.2.403. Chest. 2000. PMID: 10936132
Outcomes for patients with sarcoidosis awaiting lung transplantation.
Shorr AF, Davies DB, Nathan SD. Shorr AF, et al. Among authors: nathan sd. Chest. 2002 Jul;122(1):233-8. doi: 10.1378/chest.122.1.233. Chest. 2002. PMID: 12114364
Pulmonary embolism in idiopathic pulmonary fibrosis transplant recipients.
Nathan SD, Barnett SD, Urban BA, Nowalk C, Moran BR, Burton N. Nathan SD, et al. Chest. 2003 May;123(5):1758-63. doi: 10.1378/chest.123.5.1758. Chest. 2003. PMID: 12740298
PE patients required a longer posttransplant hospitalization (mean [+/- SD], 18.5 +/- 3.9 vs 13.5 +/- 4 days, respectively; p < 0.018). ...

PE patients required a longer posttransplant hospitalization (mean [+/- SD], 18.5 +/- 3.9 vs 13.5 +/- 4 days, respectively; p < 0.

Significance of early bronchoscopic airway abnormalities after lung transplantation.
Kelly WF, Sanghani S, Barnett SD, Burton N, Nathan S. Kelly WF, et al. Among authors: nathan s. J Heart Lung Transplant. 2003 May;22(5):583-6. doi: 10.1016/s1053-2498(02)00572-7. J Heart Lung Transplant. 2003. PMID: 12742422
Predicting mortality in patients with sarcoidosis awaiting lung transplantation.
Shorr AF, Davies DB, Nathan SD. Shorr AF, et al. Among authors: nathan sd. Chest. 2003 Sep;124(3):922-8. Chest. 2003. PMID: 12970018
The mean (+/- SD) pulmonary artery pressure in those who survived was 31.7 +/- 11.5 mm Hg, compared to 41.4 +/- 14.4 mm Hg in nonsurvivors (p < 0.01). ...
The mean (+/- SD) pulmonary artery pressure in those who survived was 31.7 +/- 11.5 mm Hg, compared to 41.4 +/- 14.4 mm Hg in nonsurv …
Sarcoidosis, race, and short-term outcomes following lung transplantation.
Shorr AF, Helman DL, Davies DB, Nathan SD. Shorr AF, et al. Among authors: nathan sd. Chest. 2004 Mar;125(3):990-6. doi: 10.1378/chest.125.3.990. Chest. 2004. PMID: 15006959
Outcomes of COPD lung transplant recipients after lung volume reduction surgery.
Nathan SD, Edwards LB, Barnett SD, Ahmad S, Burton NA. Nathan SD, et al. Chest. 2004 Nov;126(5):1569-74. doi: 10.1378/chest.126.5.1569. Chest. 2004. PMID: 15539729
Lung transplantation: disease-specific considerations for referral.
Nathan SD. Nathan SD. Chest. 2005 Mar;127(3):1006-16. doi: 10.1378/chest.127.3.1006. Chest. 2005. PMID: 15764787 Review.
Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics.
Shorr AF, Helman DL, Davies DB, Nathan SD. Shorr AF, et al. Among authors: nathan sd. Eur Respir J. 2005 May;25(5):783-8. doi: 10.1183/09031936.05.00083404. Eur Respir J. 2005. PMID: 15863633
188 results
Jump to page
Feedback